Celgene snags new approval for Otezla
U.S. FDA has approved Otezla for the treatment of adult patients with oral ulcers associated with Behçet’s Disease.
10 of the highest-paid CEOs in pharma
It’s a good time to be the top dog at a pharma company.
It’s a good time to be the top dog at a pharma company.
Pfizer’s Lyrica officially drops off the patent cliff
Pfizer’s blockbuster drug is now officially facing generics competition.
Amgen, Allergan launch first anti-cancer biosims
The drugmakers have announced the launch of Mvasi and and Kanjinti.
GSK hires new chairman as it prepares for split
GlaxoSmithKline has hired a former finance chief from Novartis and AstraZeneca as its new non-executive chairman.